Stock screening is commonly deployed by investors to ‘cut through the noise.’ The approach is especially useful when considering the thousands of options available, which can often overwhelm investors ...

Sign up to Lickd with our link for 14 days free stock music and 50% off your first mainstream chart track - Get the Infinity Pack: Green Screen Keying Episodes: Songs Used: Get Classic Rap by Andy ...

Within the Omc sector, IOC (down 2.1%) and HPCL (down 1.0%) were among the top losers. Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid ...

Shares of early cancer-detection test maker Grail plunged 50% early Friday after a landmark U.K. study showed the test didn’t significantly reduce later-stage cancer cases. Grail said late Thursday ...

Biotech stock Grail Inc (NASDAQ:GRAL) is taking a nosedive today, brushing off better-than-expected fourth-quarter results after the company's three-year cancer screening trial failed to meet its main ...

Grail’s shares plummeted more than 45% after-hours Thursday as the medtech revealed a major National Health Service (NHS) trial of its Galleri test missed its primary endpoint. In top-line data ...

We're through the busiest part of the earnings season storm, with most of the world's biggest tech firms already in. Nonetheless, this week brings numbers from two more portfolio names — plus, three ...